vs

Side-by-side financial comparison of Evolus, Inc. (EOLS) and McEwen Inc. (MUX). Click either name above to swap in a different company.

Evolus, Inc. is the larger business by last-quarter revenue ($90.3M vs $64.6M, roughly 1.4× McEwen Inc.). McEwen Inc. runs the higher net margin — 59.0% vs 0.1%, a 58.9% gap on every dollar of revenue. On growth, McEwen Inc. posted the faster year-over-year revenue change (92.8% vs 14.4%). Over the past eight quarters, McEwen Inc.'s revenue compounded faster (25.2% CAGR vs 23.4%).

Evolus, Inc. is a medical aesthetics company focused on developing and commercializing non-surgical cosmetic treatment solutions. Its flagship product is a prescription neuromodulator designed to reduce moderate to severe glabellar frown lines, serving licensed aesthetic healthcare providers and consumers across North America, Europe, and key Asia-Pacific regional markets.

McEwen Inc (ticker MUX) is a natural resource company primarily engaged in the exploration, development, and production of gold, silver, and copper assets. Its core operations are located across North and South America, serving global commodity markets with a focus on sustainable, responsible mining practices.

EOLS vs MUX — Head-to-Head

Bigger by revenue
EOLS
EOLS
1.4× larger
EOLS
$90.3M
$64.6M
MUX
Growing faster (revenue YoY)
MUX
MUX
+78.4% gap
MUX
92.8%
14.4%
EOLS
Higher net margin
MUX
MUX
58.9% more per $
MUX
59.0%
0.1%
EOLS
Faster 2-yr revenue CAGR
MUX
MUX
Annualised
MUX
25.2%
23.4%
EOLS

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
EOLS
EOLS
MUX
MUX
Revenue
$90.3M
$64.6M
Net Profit
$130.0K
$38.1M
Gross Margin
65.7%
26.9%
Operating Margin
4.7%
34.2%
Net Margin
0.1%
59.0%
Revenue YoY
14.4%
92.8%
Net Profit YoY
101.9%
563.1%
EPS (diluted)
$0.01
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EOLS
EOLS
MUX
MUX
Q4 25
$90.3M
$64.6M
Q3 25
$69.0M
$50.5M
Q2 25
$69.4M
$46.7M
Q1 25
$68.5M
$35.7M
Q4 24
$78.9M
$33.5M
Q3 24
$61.1M
$52.3M
Q2 24
$66.9M
$47.5M
Q1 24
$59.3M
$41.2M
Net Profit
EOLS
EOLS
MUX
MUX
Q4 25
$130.0K
$38.1M
Q3 25
$-15.7M
$-462.0K
Q2 25
$-17.1M
$3.0M
Q1 25
$-18.9M
$-6.3M
Q4 24
$-6.8M
$-8.2M
Q3 24
$-19.2M
$-2.1M
Q2 24
$-11.3M
$-13.0M
Q1 24
$-13.1M
$-20.4M
Gross Margin
EOLS
EOLS
MUX
MUX
Q4 25
65.7%
26.9%
Q3 25
66.5%
15.5%
Q2 25
65.3%
26.3%
Q1 25
68.1%
28.2%
Q4 24
66.7%
1.1%
Q3 24
68.9%
26.4%
Q2 24
70.3%
22.7%
Q1 24
68.3%
14.6%
Operating Margin
EOLS
EOLS
MUX
MUX
Q4 25
4.7%
34.2%
Q3 25
-16.7%
-16.7%
Q2 25
-14.7%
-7.2%
Q1 25
-22.1%
-21.4%
Q4 24
-2.9%
-43.4%
Q3 24
-25.3%
-0.2%
Q2 24
-11.5%
-29.4%
Q1 24
-15.0%
-53.3%
Net Margin
EOLS
EOLS
MUX
MUX
Q4 25
0.1%
59.0%
Q3 25
-22.8%
-0.9%
Q2 25
-24.7%
6.5%
Q1 25
-27.6%
-17.6%
Q4 24
-8.6%
-24.6%
Q3 24
-31.4%
-4.0%
Q2 24
-17.0%
-27.4%
Q1 24
-22.1%
-49.4%
EPS (diluted)
EOLS
EOLS
MUX
MUX
Q4 25
$0.01
$0.66
Q3 25
$-0.24
$-0.01
Q2 25
$-0.27
$0.06
Q1 25
$-0.30
$-0.12
Q4 24
$-0.11
$-0.15
Q3 24
$-0.30
$-0.04
Q2 24
$-0.18
$-0.26
Q1 24
$-0.22
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EOLS
EOLS
MUX
MUX
Cash + ST InvestmentsLiquidity on hand
$53.8M
$72.1M
Total DebtLower is stronger
$146.1M
$126.2M
Stockholders' EquityBook value
$-23.1M
$546.2M
Total Assets
$225.9M
$820.2M
Debt / EquityLower = less leverage
0.23×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EOLS
EOLS
MUX
MUX
Q4 25
$53.8M
$72.1M
Q3 25
$43.5M
$75.4M
Q2 25
$61.7M
$69.5M
Q1 25
$67.9M
$79.3M
Q4 24
$87.0M
$15.3M
Q3 24
$85.0M
$30.2M
Q2 24
$93.7M
$42.6M
Q1 24
$97.0M
$22.0M
Total Debt
EOLS
EOLS
MUX
MUX
Q4 25
$146.1M
$126.2M
Q3 25
$126.0M
Q2 25
$125.8M
Q1 25
$121.8M
$125.5M
Q4 24
$121.5M
$40.0M
Q3 24
$121.2M
$31.0M
Q2 24
$120.9M
$34.0M
Q1 24
$120.6M
$37.0M
Stockholders' Equity
EOLS
EOLS
MUX
MUX
Q4 25
$-23.1M
$546.2M
Q3 25
$-28.8M
$488.6M
Q2 25
$-18.7M
$484.5M
Q1 25
$-6.6M
$479.8M
Q4 24
$5.5M
$495.0M
Q3 24
$5.9M
$502.1M
Q2 24
$19.3M
$485.2M
Q1 24
$18.4M
$482.5M
Total Assets
EOLS
EOLS
MUX
MUX
Q4 25
$225.9M
$820.2M
Q3 25
$219.0M
$747.6M
Q2 25
$228.8M
$735.6M
Q1 25
$213.4M
$730.6M
Q4 24
$232.6M
$664.6M
Q3 24
$229.6M
$667.8M
Q2 24
$233.8M
$645.1M
Q1 24
$226.2M
$638.7M
Debt / Equity
EOLS
EOLS
MUX
MUX
Q4 25
0.23×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.26×
Q4 24
22.00×
0.08×
Q3 24
20.58×
0.06×
Q2 24
6.26×
0.07×
Q1 24
6.54×
0.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EOLS
EOLS
MUX
MUX
Operating Cash FlowLast quarter
$12.8M
$3.1M
Free Cash FlowOCF − Capex
$11.3M
FCF MarginFCF / Revenue
12.6%
Capex IntensityCapex / Revenue
1.6%
Cash ConversionOCF / Net Profit
98.67×
0.08×
TTM Free Cash FlowTrailing 4 quarters
$-45.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EOLS
EOLS
MUX
MUX
Q4 25
$12.8M
$3.1M
Q3 25
$-14.7M
$5.2M
Q2 25
$-24.8M
$478.0K
Q1 25
$-15.6M
$-1.9M
Q4 24
$4.8M
$-1.2M
Q3 24
$-5.7M
$23.2M
Q2 24
$-6.5M
$3.6M
Q1 24
$-10.6M
$3.9M
Free Cash Flow
EOLS
EOLS
MUX
MUX
Q4 25
$11.3M
Q3 25
$-15.6M
Q2 25
$-25.5M
Q1 25
$-16.0M
Q4 24
$4.4M
Q3 24
$-6.0M
Q2 24
$-6.9M
Q1 24
$-10.9M
FCF Margin
EOLS
EOLS
MUX
MUX
Q4 25
12.6%
Q3 25
-22.7%
Q2 25
-36.7%
Q1 25
-23.3%
Q4 24
5.5%
Q3 24
-9.9%
Q2 24
-10.4%
Q1 24
-18.3%
Capex Intensity
EOLS
EOLS
MUX
MUX
Q4 25
1.6%
Q3 25
1.4%
Q2 25
1.0%
Q1 25
0.5%
Q4 24
0.6%
Q3 24
0.5%
Q2 24
0.7%
Q1 24
0.4%
Cash Conversion
EOLS
EOLS
MUX
MUX
Q4 25
98.67×
0.08×
Q3 25
Q2 25
0.16×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons